NO910003L - Vitamin e-derivater og fremgangsmaate for deres fremstilling. - Google Patents

Vitamin e-derivater og fremgangsmaate for deres fremstilling.

Info

Publication number
NO910003L
NO910003L NO91910003A NO910003A NO910003L NO 910003 L NO910003 L NO 910003L NO 91910003 A NO91910003 A NO 91910003A NO 910003 A NO910003 A NO 910003A NO 910003 L NO910003 L NO 910003L
Authority
NO
Norway
Prior art keywords
vitamin
procedures
derivatives
preparation
Prior art date
Application number
NO91910003A
Other languages
English (en)
Other versions
NO910003D0 (no
Inventor
Noriyasu Hirose
Kimio Hamamura
Takaharu Nakamura
Kiiti Ema
Takashi Banba
Tetsuya Nakamura
Hidetoshi Kawashima
Yuuichi Inai
Noritoshi Sano
Yuko Miyauchi
Shizumasa Kijima
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO910003D0 publication Critical patent/NO910003D0/no
Publication of NO910003L publication Critical patent/NO910003L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO91910003A 1990-01-05 1991-01-02 Vitamin e-derivater og fremgangsmaate for deres fremstilling. NO910003L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000270A JPH03206089A (ja) 1990-01-05 1990-01-05 新規ビタミンｅ誘導体及びその製造方法

Publications (2)

Publication Number Publication Date
NO910003D0 NO910003D0 (no) 1991-01-02
NO910003L true NO910003L (no) 1991-07-08

Family

ID=11469218

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91910003A NO910003L (no) 1990-01-05 1991-01-02 Vitamin e-derivater og fremgangsmaate for deres fremstilling.

Country Status (8)

Country Link
US (1) US5102895A (no)
EP (1) EP0436911A3 (no)
JP (1) JPH03206089A (no)
KR (1) KR910021395A (no)
CN (1) CN1053062A (no)
CA (1) CA2033649A1 (no)
FI (1) FI906334A7 (no)
NO (1) NO910003L (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2232758C2 (ru) * 1998-09-23 2004-07-20 Рисерч Дивелопмент Фаундейшн Токоферолы, токотриенолы и другие производные хромана и боковых цепей и способы лечения с их использованием
US6703384B2 (en) 1998-09-23 2004-03-09 Research Development Foundation Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
CN1243000C (zh) 2000-02-11 2006-02-22 研究发展基金会 生育酚、生育三烯酚、其它苯并二氢吡喃和侧链衍生物,及其用途
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
KR100453727B1 (ko) * 2001-01-30 2004-10-20 김영대 신규한 폴리옥시프로필렌폴리옥시에틸렌 비타민 ｅ 및그의 제조방법
AU2002317053B2 (en) 2001-07-27 2004-08-05 Vital Health Sciences Pty Ltd Dermal therapy using phosphate derivatives of electron transfer agents
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
BRPI0406484A (pt) * 2003-01-17 2005-12-06 Vital Health Sciences Pty Ltd Método de inibição da ocorrência de uma ou mais das seguintes condições: a proliferação de monócitos/macrófagos; ou a proliferação de células do músculo liso; ou a expressão de receptores de cd36; ou a absorção de lipoproteìna de baixa densidade - ldl oxidada, método de alìvio de sintomas de tratamento ou prevenção de aterosclerose; de diabetes; do mal de alzheimer, método de inibição da ocorrência da formação de placas no sistema vascular, método de alìvio da inflamação associada a ocorrência de uma ou de mais das seguintes condições: a proliferação de monócitos, a proliferação de células do músculo liso, a expressão de ldl oxidadas ou de receptor descontaminante, composição farmacêutica, uso de uma quantidade eficaz de um ou mais derivados ou fosfato de um ou mais agentes de transferência de elétrons conjuntamente com um veìculo ou um diluente apropriado, uso de uma quantidade eficaz de um ou mais derivados de fosfato de (alfa)-tocoferol conjuntamente com um veìculo ou um diluente apropriado e uso de uma quantidade eficaz de um ou mais derivados de fosfato de um ou mais agentes de transferência de elétrons selecionados do grupo que consiste em fosfato mono-tocoferila, fosfato de di-tocoferila e as misturas destes conjuntamente com um veìculo ou um diluente apropriado
AU2003900200A0 (en) * 2003-01-17 2003-01-30 Vital Health Sciences Pty Ltd Compounds having antiproliferative properties
CA2557354C (en) 2004-03-03 2013-05-07 Vital Health Sciences Pty Ltd. Alkaloid formulations
CN100334080C (zh) * 2005-06-01 2007-08-29 华东理工大学 苯并二氢吡喃碳糖苷衍生物
MX2007015949A (es) 2005-06-17 2008-03-07 Vital Health Sciences Pty Ltd Un vehiculo que comprende uno o mas derivados de fosfato de di- y/o mono-(agentes de transferencia de electrones) o complejos de los mismos.
US10071030B2 (en) 2010-02-05 2018-09-11 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
JP5806287B2 (ja) 2010-03-30 2015-11-10 フォスファジェニクス リミティド 経皮送達パッチ
WO2012122586A1 (en) 2011-03-15 2012-09-20 Phosphagenics Limited New composition
CN102816153B (zh) * 2012-09-07 2015-01-21 浙江新赛科药业有限公司 一种合成ve烟酸酯的方法
MX383940B (es) 2015-12-09 2025-03-14 Phosphagenics Ltd Formulación farmacéutica que contiene tocol fosfato.
JP7198754B2 (ja) 2016-12-21 2023-01-04 アベーチョ バイオテクノロジー リミテッド 方法
KR102070081B1 (ko) 2017-11-01 2020-01-29 한양대학교 에리카산학협력단 새로운 비타민 e 기반의 양친매성 화합물 및 이의 활용
CN114047267B (zh) * 2021-11-15 2023-11-21 贵州省烟草科学研究院 一种衍生化-气相色谱-质谱方法分析烟草根系中烟酸的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681890A (en) * 1984-10-30 1987-07-21 Kuraray Co., Ltd. 3,4-dihydrobenzopyran compounds and pharmaceutical composition containing the same

Also Published As

Publication number Publication date
FI906334A7 (fi) 1991-07-06
US5102895A (en) 1992-04-07
EP0436911A2 (en) 1991-07-17
JPH03206089A (ja) 1991-09-09
CA2033649A1 (en) 1991-07-06
FI906334A0 (fi) 1990-12-20
NO910003D0 (no) 1991-01-02
EP0436911A3 (en) 1991-07-24
CN1053062A (zh) 1991-07-17
KR910021395A (ko) 1991-12-20

Similar Documents

Publication Publication Date Title
NO893678D0 (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
NO900577L (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
NO924650D0 (no) Dialkoksy-pyridinyl-benzimidazolderivater, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse
NO881660D0 (no) Hepariner og femgangsmaate for deres fremstilling.
NO891866D0 (no) Kromanderivater og fremgangsmaate for fremstilling derav.
NO922275L (no) Aryletere, deres fremstilling og fremgangsmaate for behandling
NO910003D0 (no) Vitamin e derivater og fremgangsmaate for deres fremstilling.
NO904551D0 (no) Quinolonforbindelser og fremgangsmaate for deres fremstilling.
NO875358D0 (no) 6-benzoksazinyl- og 6-benzotiazinyl-2,3,4,5-tetrahydropyridazin-3-oner og fremgangsmaate for deres fremstilling.
NO870512L (no) 1,4-benzoksazinderivater og fremgangsmaate for deres fremstilling.
NO893196D0 (no) Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling.
NO902279L (no) Benzocykloalkanderivater og deres fremstilling.
NO903636L (no) Makrocykliske forbindelser og fremgangsmaate for deres fremstilling.
NO895030D0 (no) 2-imino-benzotiazolinderivater og deres fremstilling.
NO892494D0 (no) Kromanderivater og fremgangsmaate for fremstilling derav.
NO903096D0 (no) Termotrope semialifatiske kopolyesteramider og deres fremstilling.
NO904552L (no) Quinolonforbindelser og fremgangsmaate for deres fremstilling.
NO894103L (no) Kromanderivater og fremgangsmaate for fremstilling derav.
NO911047D0 (no) Labdaner og fremgangsmaate for deres fremstilling.
NO883114D0 (no) 1h-pyrazol-1-alkanamider og fremgangsmaate for deres fremstilling.
NO924343L (no) Substituerte 1,5 pentandioler og deres fremstilling
NO900252L (no) Cefasporinderivater og fremgangsmaate for fremstilling derav.
NO893653D0 (no) Quinolinderivater og deres fremstilling.
NO893565L (no) Etansulfonamidderivater og fremgangsmaate for deres fremstilling.
NO903484D0 (no) Substituerte pyrazinderivater og fremgangsmaate for deres fremstilling.